Rules & Regulations of the State of Tennessee
Title 0520 - Education
Subtitle 0520-01 - State Board of Education Rules, Regulations, and Minimum Standards for the Operation of the Public School System
Chapter 0520-01-13 - School and Student Health Services
Section 0520-01-13-.05 - ADMINISTRATION OF AN OPIOID ANTAGONIST

(1) Each school within an LEA and each nonpublic school is authorized to adopt a policy to maintain an opioid antagonist so that an opioid antagonist may be administered to any student believed to be having a drug overdose.

(2) Each LEA or nonpublic school that adopts a policy to maintain an opioid antagonist shall include a provision for parental notification. Administration of an opioid antagonist shall be in compliance with the procedures outlined in the Guidelines for Use of Health Care Professionals and Health Care Procedures in a School Setting produced by the Department of Education and the Department of Health.

(3) Naloxone, an opioid antagonist, is to be used when there is suspicion of an opioid overdose. Naloxone is available as an auto-injector or an intranasal spray. Each LEA that adopts a policy to maintain an opioid antagonist shall decide which form of Naloxone will be kept in schools.

(4) School personnel, including school nurses, who might administer naloxone in a suspected overdose must complete the Tennessee Department of Health training on Naloxone administration. The certificate of training completion must be kept in the employee's file.

(5) Each school within an LEA and each nonpublic school is authorized to maintain Naloxone in at least two unlocked, secure locations to be determined by each school. Naloxone should be stored according to the manufacturer's instructions. Each LEA should develop a procedure for maintaining an inventory documenting the quantities, locations, and expirations of Naloxone, proper storage, and documentation of replacement units.

(6) In the case of a suspected opioid overdose, school nurses or other trained school personnel shall follow the protocols outlined in the Naloxone training and the instructions in the Naloxone kit.

(7) Each LEA that adopts a policy to maintain an opioid antagonist, shall develop a Naloxone receipt form with storage information as well as a use reporting form which should be completed after any incident involving the use of Naloxone.